Eytan Ruppin

Pangea Therapeutics Ltd. is an Israeli company that specializes in developing a proprietary tumor intelligence platform called Technology Enlight. The company is based in Tel Aviv, Israel. This platform enables a deeper understanding of how a tumor would respond to therapy by considering expression abnormalities, which are more common than actionable mutations. By combining these with tumor vulnerability maps, the platform uncovers many more clinically relevant insights than approaches based solely on genomic alterations. The company was founded by Eytan Ruppin, Eyal Gottlieb, Ze'ev Ronai. The CEO is Tuvik Beker.

Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel.

Soligence Corp. provided cellular expense management solutions. The company was founded by Yuval Spector and Tuvik Beker in 2002 and was headquartered in Palo Alto, CA.

MedAware Ltd. develops a software platform for the medical prescription market. Its software platform integrated with the electronic health record that detects the likelihood of a medication error. The firm offers alerting and risk management decision support tools. The company was founded by Gidi Stein and Tuvik Beker in 2012 and is headquartered in Raanana, Israel.